Skip to main content
. Author manuscript; available in PMC: 2020 Sep 21.
Published in final edited form as: Pharmacogenomics J. 2015 Mar 10;15(6):521–529. doi: 10.1038/tpj.2015.14

Figure 4.

Figure 4.

(a) Recursive Partitioning for RFS. Light gray ovals represent intermediate subgroups; light gray squares represent terminal nodes. Dark gray rectangles indicate predictive polymorphism. Fractions within nodes indicate patients who relapsed per total patients with that node. Node 1 represents intermediate-risk patients. Node 2 represents high-risk patients. (b) Kaplan–Meier curves for RFS nodes. HR, hazard ratio; RFS, recurrence-free survival.